• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏性猝死的预防策略

Strategies for Sudden Cardiac Death Prevention.

作者信息

Corianò Mattia, Tona Francesco

机构信息

Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, 35128 Padova, Italy.

出版信息

Biomedicines. 2022 Mar 10;10(3):639. doi: 10.3390/biomedicines10030639.

DOI:10.3390/biomedicines10030639
PMID:35327441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8944952/
Abstract

Sudden cardiac death (SCD) represents a major challenge in modern medicine. The prevention of SCD orbits on two levels, the general population level and individual level. Much research has been done with the aim to improve risk stratification of SCD, although no radical changes in evidence and in therapeutic strategy have been achieved. Artificial intelligence (AI), and in particular machine learning (ML) models, represent novel technologic tools that promise to improve predictive ability of fatal arrhythmic events. In this review, firstly, we analyzed the electrophysiological basis and the major clues of SCD prevention at population and individual level; secondly, we reviewed the main research where ML models were used for risk stratification in other field of cardiology, suggesting its potentiality in the field of SCD prevention.

摘要

心脏性猝死(SCD)是现代医学面临的一项重大挑战。SCD的预防分为两个层面,即普通人群层面和个体层面。尽管在证据和治疗策略方面尚未取得根本性改变,但为改善SCD的风险分层已开展了大量研究。人工智能(AI),尤其是机器学习(ML)模型,是有望提高致命性心律失常事件预测能力的新型技术工具。在本综述中,首先,我们分析了SCD预防在人群和个体层面的电生理基础及主要线索;其次,我们回顾了将ML模型用于心脏病学其他领域风险分层的主要研究,提示其在SCD预防领域的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbdc/8944952/dc981aa85c44/biomedicines-10-00639-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbdc/8944952/9ccb3aecd953/biomedicines-10-00639-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbdc/8944952/530288fed158/biomedicines-10-00639-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbdc/8944952/e4a7be5d7c0c/biomedicines-10-00639-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbdc/8944952/dc981aa85c44/biomedicines-10-00639-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbdc/8944952/9ccb3aecd953/biomedicines-10-00639-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbdc/8944952/530288fed158/biomedicines-10-00639-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbdc/8944952/e4a7be5d7c0c/biomedicines-10-00639-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbdc/8944952/dc981aa85c44/biomedicines-10-00639-g004.jpg

相似文献

1
Strategies for Sudden Cardiac Death Prevention.心脏性猝死的预防策略
Biomedicines. 2022 Mar 10;10(3):639. doi: 10.3390/biomedicines10030639.
2
Prediction of sudden cardiac death using artificial intelligence: Current status and future directions.使用人工智能预测心源性猝死:现状与未来方向。
Heart Rhythm. 2025 Mar;22(3):756-766. doi: 10.1016/j.hrthm.2024.09.003. Epub 2024 Sep 6.
3
A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy.基于机器学习的肥厚型心肌病伴室性心动过速和心力衰竭风险分层模型。
Comput Biol Med. 2021 Aug;135:104648. doi: 10.1016/j.compbiomed.2021.104648. Epub 2021 Jul 12.
4
Artificial Intelligence ECG Analysis in Patients with Short QT Syndrome to Predict Life-Threatening Arrhythmic Events.人工智能心电图分析在短 QT 综合征患者中的应用,以预测威胁生命的心律失常事件。
Sensors (Basel). 2023 Nov 1;23(21):8900. doi: 10.3390/s23218900.
5
Long-term risk of sudden cardiac death in hypertrophic cardiomyopathy: a cardiac magnetic resonance outcome study.肥厚型心肌病患者发生心源性猝死的长期风险:一项心脏磁共振结局研究。
Eur Heart J Cardiovasc Imaging. 2021 Jun 22;22(7):732-741. doi: 10.1093/ehjci/jeaa423.
6
For Whom the Bell Tolls : Refining Risk Assessment for Sudden Cardiac Death.《钟声为谁而鸣:完善心源性猝死风险评估》。
Curr Cardiol Rep. 2019 Aug 2;21(9):106. doi: 10.1007/s11886-019-1191-z.
7
Validation of the new American College of Cardiology/American Heart Association Guidelines for the risk stratification of sudden cardiac death in a large Mediterranean cohort with Hypertrophic Cardiomyopathy.新的美国心脏病学会/美国心脏协会指南在一个大型地中海肥厚型心肌病队列中对心源性猝死风险分层的验证。
Hellenic J Cardiol. 2022 Jan-Feb;63:15-21. doi: 10.1016/j.hjc.2021.06.005. Epub 2021 Jun 17.
8
Abnormalities in sodium current and calcium homoeostasis as drivers of arrhythmogenesis in hypertrophic cardiomyopathy.钠电流和钙稳态异常作为肥厚型心肌病心律失常发生的驱动因素。
Cardiovasc Res. 2020 Jul 15;116(9):1585-1599. doi: 10.1093/cvr/cvaa124.
9
Improvement in sudden cardiac death risk prediction by the enhanced American College of Cardiology/American Heart Association strategy in Chinese patients with hypertrophic cardiomyopathy.增强的美国心脏病学会/美国心脏协会策略可改善中国肥厚型心肌病患者的心脏性猝死风险预测。
Heart Rhythm. 2020 Oct;17(10):1658-1663. doi: 10.1016/j.hrthm.2020.04.017. Epub 2020 Apr 18.
10
Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy.美国心脏病学会/美国心脏协会优化的肥厚型心肌病高危患者心源性猝死预防策略。
JAMA Cardiol. 2019 Jul 1;4(7):644-657. doi: 10.1001/jamacardio.2019.1391.

引用本文的文献

1
Management Status of Myocarditis-Related Sudden Cardiac Death.心肌炎相关心源性猝死的管理现状
Rev Cardiovasc Med. 2024 Dec 23;25(12):452. doi: 10.31083/j.rcm2512452. eCollection 2024 Dec.
2
Sudden cardiac death among workers: a systematic review and meta-analysis.工人群体中的心源性猝死:一项系统评价和荟萃分析。
Syst Rev. 2024 Mar 9;13(1):84. doi: 10.1186/s13643-024-02504-5.
3
Deep learning-based prediction of major arrhythmic events in dilated cardiomyopathy: A proof of concept study.基于深度学习的扩张型心肌病主要心律失常事件预测:概念验证研究。

本文引用的文献

1
Artificial intelligence in cardiovascular imaging-principles, expectations, and limitations.心血管成像中的人工智能——原理、期望与局限
Eur Heart J. 2021 Sep 24;45(15):1322-6. doi: 10.1093/eurheartj/ehab678.
2
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.2021年欧洲心脏病学会临床实践中心血管疾病预防指南。
Eur Heart J. 2021 Sep 7;42(34):3227-3337. doi: 10.1093/eurheartj/ehab484.
3
CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter-Defibrillator in Non-Ischemic Cardiomyopathy.
PLoS One. 2024 Feb 29;19(2):e0297793. doi: 10.1371/journal.pone.0297793. eCollection 2024.
4
Galectin-3 Is Associated with Cardiac Fibrosis and an Increased Risk of Sudden Death.半乳糖凝集素-3 与心脏纤维化和猝死风险增加相关。
Cells. 2023 Apr 23;12(9):1218. doi: 10.3390/cells12091218.
基于 CMR 的非缺血性心肌病患者心源性猝死风险分层与植入式心脏复律除颤器的应用。
Int J Mol Sci. 2021 Jul 1;22(13):7115. doi: 10.3390/ijms22137115.
4
SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.SCORE2-OP 风险预测算法:估计四个地理风险地区老年人的新发心血管事件风险。
Eur Heart J. 2021 Jul 1;42(25):2455-2467. doi: 10.1093/eurheartj/ehab312.
5
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe.SCORE2 风险预测算法:用于评估欧洲人群 10 年心血管疾病风险的新模型。
Eur Heart J. 2021 Jul 1;42(25):2439-2454. doi: 10.1093/eurheartj/ehab309.
6
Prognostic value of late gadolinium enhancement in arrhythmogenic right ventricular cardiomyopathy: a meta-analysis.致心律失常性右室心肌病晚期钆增强的预后价值:一项荟萃分析。
Clin Radiol. 2021 Aug;76(8):628.e9-628.e15. doi: 10.1016/j.crad.2021.04.002. Epub 2021 May 20.
7
Machine Learning and the Future of Cardiovascular Care: JACC State-of-the-Art Review.机器学习与心血管病护理的未来:《美国心脏病学会杂志》观点述评。
J Am Coll Cardiol. 2021 Jan 26;77(3):300-313. doi: 10.1016/j.jacc.2020.11.030.
8
Explainable AI: A Review of Machine Learning Interpretability Methods.可解释人工智能:机器学习可解释性方法综述
Entropy (Basel). 2020 Dec 25;23(1):18. doi: 10.3390/e23010018.
9
Prognostic value of texture analysis from cardiac magnetic resonance imaging in patients with Takotsubo syndrome: a machine learning based proof-of-principle approach.基于机器学习的 Takotsubo 综合征患者心脏磁共振成像纹理分析的预后价值:原理验证研究。
Sci Rep. 2020 Nov 25;10(1):20537. doi: 10.1038/s41598-020-76432-4.
10
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020年美国心脏协会/美国心脏病学会肥厚型心肌病患者诊断和治疗指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
J Am Coll Cardiol. 2020 Dec 22;76(25):e159-e240. doi: 10.1016/j.jacc.2020.08.045. Epub 2020 Nov 20.